biospecimen_aliquot__bcr_aliquot_barcode	tcga-ac-a2fe-01a-11d-a19y-09
biospecimen_aliquot__bcr_aliquot_uuid	f97dcfdf-eed2-4844-8547-162917143704
biospecimen_aliquot__bcr_patient_uuid	f6eebd4b-b63a-4a9c-92d3-0d954a8a6655
biospecimen_aliquot__bcr_sample_barcode	tcga-ac-a2fe-01a
biospecimen_aliquot__biospecimen_barcode_bottom	0118968211
biospecimen_aliquot__center_id	09
biospecimen_aliquot__concentration	0.08
biospecimen_aliquot__date_of_shipment	2011-11-30
biospecimen_aliquot__is_derived_from_ffpe	no
biospecimen_aliquot__plate_column	6
biospecimen_aliquot__plate_id	a19y
biospecimen_aliquot__plate_row	c
biospecimen_aliquot__quantity	3.20
biospecimen_aliquot__source_center	23
biospecimen_aliquot__volume	40.00
biospecimen_analyte__analyte_type	dna
biospecimen_analyte__analyte_type_id	d
biospecimen_analyte__bcr_analyte_barcode	tcga-ac-a2fe-01a-11d
biospecimen_analyte__bcr_analyte_uuid	857440e4-ec04-4f06-bbfa-cef321a369b8
biospecimen_analyte__bcr_patient_uuid	f6eebd4b-b63a-4a9c-92d3-0d954a8a6655
biospecimen_analyte__bcr_sample_barcode	tcga-ac-a2fe-01a
biospecimen_analyte__concentration	0.16
biospecimen_analyte__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen_analyte__is_derived_from_ffpe	no
biospecimen_analyte__normal_tumor_genotype_match	yes
biospecimen_analyte__pcr_amplification_successful	yes
biospecimen_analyte__spectrophotometer_method	picogreen
biospecimen_analyte__subportion_sequence	1
biospecimen_diagnostic_slides__bcr_patient_barcode	tcga-ac-a2fe
biospecimen_diagnostic_slides__bcr_patient_uuid	f6eebd4b-b63a-4a9c-92d3-0d954a8a6655
biospecimen_diagnostic_slides__bcr_sample_barcode	tcga-ac-a2fe-01a
biospecimen_diagnostic_slides__ffpe_slide_uuid	c036ae58-3c0d-4dbf-b658-296d03fd6701
biospecimen_normal_control__bcr_patient_barcode	tcga-ac-a2fe
biospecimen_normal_control__bcr_patient_uuid	f6eebd4b-b63a-4a9c-92d3-0d954a8a6655
biospecimen_normal_control__normal_tissue_anatomic_site	breast
biospecimen_portion__bcr_patient_uuid	f6eebd4b-b63a-4a9c-92d3-0d954a8a6655
biospecimen_portion__bcr_portion_barcode	tcga-ac-a2fe-01a-11
biospecimen_portion__bcr_portion_uuid	18251b3a-29a2-459c-b895-b0597014078c
biospecimen_portion__bcr_sample_barcode	tcga-ac-a2fe-01a
biospecimen_portion__date_of_creation	2011-06-21
biospecimen_portion__is_ffpe	no
biospecimen_portion__portion_number	11
biospecimen_portion__portion_sequence	1
biospecimen_portion__weight	30.00
biospecimen_protocol__bcr_analyte_barcode	tcga-ac-a2fe-01a-11d
biospecimen_protocol__bcr_patient_uuid	f6eebd4b-b63a-4a9c-92d3-0d954a8a6655
biospecimen_protocol__bcr_sample_barcode	tcga-ac-a2fe-01a
biospecimen_protocol__experimental_protocol_type	adna preparation type
biospecimen_sample__bcr_patient_uuid	f6eebd4b-b63a-4a9c-92d3-0d954a8a6655
biospecimen_sample__bcr_sample_barcode	tcga-ac-a2fe-01a
biospecimen_sample__bcr_sample_uuid	9439bb31-588c-433b-a7a5-787d8b496f57
biospecimen_sample__days_to_collection	2228
biospecimen_sample__initial_weight	120
biospecimen_sample__is_ffpe	no
biospecimen_sample__oct_embedded	false
biospecimen_sample__pathology_report_file_name	tcga-ac-a2fe.f694cbd6-880d-40c7-ab17-d0ad02b7f06b.pdf
biospecimen_sample__pathology_report_uuid	f694cbd6-880d-40c7-ab17-d0ad02b7f06b
biospecimen_sample__sample_type	primary tumor
biospecimen_sample__sample_type_id	01
biospecimen_sample__vial_number	a
biospecimen_shipment_portion__bcr_patient_uuid	f6eebd4b-b63a-4a9c-92d3-0d954a8a6655
biospecimen_shipment_portion__bcr_sample_barcode	tcga-ac-a2fe-01a
biospecimen_shipment_portion__bcr_shipment_portion_uuid	419206c6-a1d6-4541-b154-10aae75b04a2
biospecimen_shipment_portion__center_id	20
biospecimen_shipment_portion__is_ffpe	no
biospecimen_shipment_portion__plate_id	a24a
biospecimen_shipment_portion__portion_number	21
biospecimen_shipment_portion__portion_sequence	2
biospecimen_shipment_portion__shipment_portion_bcr_aliquot_barcode	tcga-ac-a2fe-01a-21-a24a-20
biospecimen_shipment_portion__shipment_portion_day_of_shipment	14
biospecimen_shipment_portion__shipment_portion_month_of_shipment	11
biospecimen_shipment_portion__shipment_portion_year_of_shipment	2012
biospecimen_slide__bcr_patient_uuid	f6eebd4b-b63a-4a9c-92d3-0d954a8a6655
biospecimen_slide__bcr_sample_barcode	tcga-ac-a2fe-01a
biospecimen_slide__bcr_slide_barcode	tcga-ac-a2fe-01a-01-tsa
biospecimen_slide__bcr_slide_uuid	25ee517d-ceee-4ffc-ae49-d0f1d3303882
biospecimen_slide__image_file_name	tcga-ac-a2fe-01a-01-tsa.25ee517d-ceee-4ffc-ae49-d0f1d3303882.svs
biospecimen_slide__is_derived_from_ffpe	no
biospecimen_slide__percent_lymphocyte_infiltration	0
biospecimen_slide__percent_monocyte_infiltration	0
biospecimen_slide__percent_necrosis	0
biospecimen_slide__percent_neutrophil_infiltration	0
biospecimen_slide__percent_normal_cells	40
biospecimen_slide__percent_stromal_cells	25
biospecimen_slide__percent_tumor_cells	35
biospecimen_slide__percent_tumor_nuclei	75
biospecimen_slide__section_location	top
biospecimen_tumor_sample__bcr_patient_barcode	tcga-ac-a2fe
biospecimen_tumor_sample__bcr_patient_uuid	f6eebd4b-b63a-4a9c-92d3-0d954a8a6655
clinical_drug__bcr_drug_barcode	tcga-ac-a2fe-d37370
clinical_drug__bcr_drug_uuid	4df74c32-567b-4238-b008-44ba2231ac3a
clinical_drug__bcr_patient_barcode	tcga-ac-a2fe
clinical_drug__bcr_patient_uuid	f6eebd4b-b63a-4a9c-92d3-0d954a8a6655
clinical_drug__form_completion_date	2012-12-3
clinical_drug__pharmaceutical_therapy_drug_name	arimidex
clinical_drug__pharmaceutical_therapy_type	hormone therapy
clinical_drug__pharmaceutical_tx_started_days_to	273
clinical_drug__tx_on_clinical_trial	no
clinical_follow_up__bcr_followup_barcode	tcga-ac-a2fe-f47723
clinical_follow_up__bcr_followup_uuid	d5adec6c-7eea-4059-a611-d95c59be08dd
clinical_follow_up__bcr_patient_barcode	tcga-ac-a2fe
clinical_follow_up__bcr_patient_uuid	f6eebd4b-b63a-4a9c-92d3-0d954a8a6655
clinical_follow_up__followup_lost_to	no
clinical_follow_up__form_completion_date	2013-8-28
clinical_follow_up__last_contact_days_to	2240
clinical_follow_up__new_tumor_event_dx_days_to	766
clinical_follow_up__new_tumor_event_dx_indicator	yes
clinical_follow_up__new_tumor_event_pharmaceutical_tx	no
clinical_follow_up__new_tumor_event_radiation_tx	yes
clinical_follow_up__new_tumor_event_site	bone
clinical_follow_up__new_tumor_event_surgery	no
clinical_follow_up__new_tumor_event_type	distant metastasis
clinical_follow_up__pharmaceutical_tx_adjuvant	yes
clinical_follow_up__radiation_treatment_adjuvant	yes
clinical_follow_up__tumor_status	with tumor
clinical_follow_up__vital_status	alive
clinical_nte__bcr_patient_barcode	tcga-ac-a2fe
clinical_nte__bcr_patient_uuid	f6eebd4b-b63a-4a9c-92d3-0d954a8a6655
clinical_nte__new_tumor_event_dx_days_to	766
clinical_nte__new_tumor_event_pharmaceutical_tx	no
clinical_nte__new_tumor_event_radiation_tx	yes
clinical_nte__new_tumor_event_site	bone
clinical_nte__new_tumor_event_surgery	no
clinical_nte__new_tumor_event_type	distant metastasis
clinical_patient__age_at_diagnosis	62
clinical_patient__ajcc_metastasis_pathologic_pm	mx
clinical_patient__ajcc_nodes_pathologic_pn	n3a
clinical_patient__ajcc_pathologic_tumor_stage	stage iiic
clinical_patient__ajcc_staging_edition	6th
clinical_patient__ajcc_tumor_pathologic_pt	t3
clinical_patient__anatomic_neoplasm_subdivision	right upper outer quadrant
clinical_patient__axillary_staging_method	sentinel lymph node biopsy plus axillary dissection
clinical_patient__bcr_patient_barcode	tcga-ac-a2fe
clinical_patient__bcr_patient_uuid	f6eebd4b-b63a-4a9c-92d3-0d954a8a6655
clinical_patient__birth_days_to	-22746
clinical_patient__days_to_initial_pathologic_diagnosis	0
clinical_patient__er_status_by_ihc	positive
clinical_patient__er_status_ihc_Percent_Positive	60-69%
clinical_patient__ethnicity	not hispanic or latino
clinical_patient__form_completion_date	2012-12-3
clinical_patient__gender	female
clinical_patient__histological_type	infiltrating lobular carcinoma
clinical_patient__history_neoadjuvant_treatment	no
clinical_patient__history_other_malignancy	no
clinical_patient__icd_10	c50.9
clinical_patient__icd_o_3_histology	8520/3
clinical_patient__icd_o_3_site	c50.9
clinical_patient__informed_consent_verified	yes
clinical_patient__initial_pathologic_dx_year	2005
clinical_patient__last_contact_days_to	791
clinical_patient__lymph_nodes_examined	yes
clinical_patient__lymph_nodes_examined_count	18
clinical_patient__lymph_nodes_examined_he_count	18
clinical_patient__margin_status	negative
clinical_patient__menopause_status	post (prior bilateral ovariectomy or >12 mo since lmp with no prior hysterectomy)
clinical_patient__method_initial_path_dx	fine needle aspiration biopsy
clinical_patient__micromet_detection_by_ihc	no
clinical_patient__new_tumor_event_dx_indicator	yes
clinical_patient__patient_id	a2fe
clinical_patient__pharmaceutical_tx_adjuvant	yes
clinical_patient__pr_status_by_ihc	positive
clinical_patient__pr_status_ihc_percent_positive	<10%
clinical_patient__prospective_collection	no
clinical_patient__race	white
clinical_patient__radiation_treatment_adjuvant	yes
clinical_patient__retrospective_collection	yes
clinical_patient__surgical_procedure_first	modified radical mastectomy
clinical_patient__tissue_source_site	ac
clinical_patient__tumor_status	with tumor
clinical_patient__tumor_tissue_site	breast
clinical_patient__vital_status	alive
clinical_radiation__bcr_patient_barcode	tcga-ac-a2fe
clinical_radiation__bcr_patient_uuid	f6eebd4b-b63a-4a9c-92d3-0d954a8a6655
clinical_radiation__bcr_radiation_barcode	tcga-ac-a2fe-r37371
clinical_radiation__bcr_radiation_uuid	fa6dfce6-f2f8-4d52-b805-c1b07a828c99
clinical_radiation__form_completion_date	2012-12-3
clinical_radiation__radiation_therapy_ended_days_to	813
clinical_radiation__radiation_therapy_ongoing_indicator	no
clinical_radiation__radiation_therapy_site	distant site
clinical_radiation__radiation_therapy_started_days_to	791
clinical_radiation__radiation_therapy_type	external
clinical_radiation__treatment_best_response	partial response
manually_curated__center	genome.wustl.edu
manually_curated__dataType	dnaseq
manually_curated__exp_data_bed_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-AC-A2FE-01A-11D-A19Y-09.bed
manually_curated__exp_metadata_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-AC-A2FE-01A-11D-A19Y-09.bed.meta
manually_curated__id	tcga-ac-a2fe-01a-11d-a19y-09
manually_curated__md5sum	8b2303f40bb96df462a775d813f677b2
manually_curated__ncbi_build	37
manually_curated__seqPlatform	illumina_ga2
manually_curated__sequence_source	wxs
manually_curated__sequencer	illumina gaiix
manually_curated__tissue_status	tumoral
manually_curated__tumor_description	breast invasive carcinoma
manually_curated__tumor_sample_uuid	f97dcfdf-eed2-4844-8547-162917143704
manually_curated__tumor_tag	brca
